CA2961393A1 - Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor - Google Patents

Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor Download PDF

Info

Publication number
CA2961393A1
CA2961393A1 CA2961393A CA2961393A CA2961393A1 CA 2961393 A1 CA2961393 A1 CA 2961393A1 CA 2961393 A CA2961393 A CA 2961393A CA 2961393 A CA2961393 A CA 2961393A CA 2961393 A1 CA2961393 A1 CA 2961393A1
Authority
CA
Canada
Prior art keywords
hydroxy
amino
oxadiazole
thio
methyl sulfoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2961393A
Other languages
English (en)
French (fr)
Inventor
Zhaoyin Wang
Wei Guo
Jidong ZHU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Organic Chemistry
Original Assignee
Shanghai Institute of Organic Chemistry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Organic Chemistry filed Critical Shanghai Institute of Organic Chemistry
Publication of CA2961393A1 publication Critical patent/CA2961393A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2961393A 2014-09-15 2015-09-15 Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor Abandoned CA2961393A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201410468433.XA CN105481789B (zh) 2014-09-15 2014-09-15 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法
CN201410468433.X 2014-09-15
PCT/CN2015/089666 WO2016041489A1 (zh) 2014-09-15 2015-09-15 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法

Publications (1)

Publication Number Publication Date
CA2961393A1 true CA2961393A1 (en) 2016-03-24

Family

ID=55532557

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2961393A Abandoned CA2961393A1 (en) 2014-09-15 2015-09-15 Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor

Country Status (6)

Country Link
US (1) US11053207B2 (enExample)
EP (1) EP3196197A4 (enExample)
JP (1) JP6317034B2 (enExample)
CN (2) CN105481789B (enExample)
CA (1) CA2961393A1 (enExample)
WO (1) WO2016041489A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105481789B (zh) * 2014-09-15 2020-05-19 中国科学院上海有机化学研究所 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法
CN106883193B (zh) * 2015-12-15 2021-10-15 上海翰森生物医药科技有限公司 吲哚胺2,3-双加氧酶抑制剂及其制备方法与应用
CN107176933B (zh) * 2016-03-09 2020-10-09 中国科学院上海有机化学研究所 一种含氮烷基化和芳基化亚砜亚胺的吲哚胺-2,3-双加氧酶抑制剂
CN107304191B (zh) * 2016-04-20 2023-09-29 上海翰森生物医药科技有限公司 吲哚胺2,3-双加氧酶抑制剂及其制备方法与应用
WO2017181849A1 (zh) * 2016-04-20 2017-10-26 江苏豪森药业集团有限公司 吲哚胺2,3-双加氧酶抑制剂及其制备方法与应用
CN106109472A (zh) * 2016-06-13 2016-11-16 中山大学 氯氮卓作为吲哚胺2,3-双加氧酶-1抑制剂的用途
US20190169140A1 (en) * 2016-08-02 2019-06-06 Shandong Luye Pharmaceutical Co., Ltd. Ido1 inhibitor and preparation method and application thereof
CN107954999B (zh) * 2016-10-17 2023-01-24 上海医药集团股份有限公司 含噁二唑环化合物、制备方法、中间体、组合物及应用
UY37466A (es) 2016-11-03 2018-01-31 Phenex Discovery Verwaltungs Gmbh N-hidroxiamidinheterociclos sustituidos como moduladores de la indolamina 2,3-dioxigenasa
US11168078B2 (en) 2016-11-28 2021-11-09 Shanghai Fochon Pharmaceutical Co., Ltd. Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase
CN108218807A (zh) * 2016-12-22 2018-06-29 上海长森药业有限公司 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途
CN106883224B (zh) * 2017-01-03 2019-10-22 中国药科大学 苯并含氮杂环类吲哚胺-2,3-双加氧酶1抑制剂及其用途
CN106866648B (zh) * 2017-01-03 2019-10-22 中国药科大学 邻苯二甲酰亚胺类吲哚胺-2,3-双加氧酶1抑制剂及其用途
WO2018136437A2 (en) 2017-01-17 2018-07-26 Tesaro, Inc. Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US10927086B2 (en) 2017-02-24 2021-02-23 Merck Sharp & Dohme Corp. Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
CN108689958B (zh) * 2017-04-05 2021-09-17 南京华威医药科技集团有限公司 一种含有肼基的吲哚胺2,3-双加氧化酶抑制剂
CN108727361A (zh) * 2017-04-24 2018-11-02 南京药捷安康生物科技有限公司 吲哚胺2,3-双加氧酶抑制剂与应用
CN109081818B (zh) * 2017-06-14 2022-04-22 南京华威医药科技集团有限公司 新型吲哚胺2,3-双加氧化酶抑制剂
WO2019057104A1 (zh) * 2017-09-20 2019-03-28 上海翰森生物医药科技有限公司 一种双加氧酶抑制剂的盐及其制备方法和用途
CN109678813A (zh) * 2017-10-18 2019-04-26 中国科学院上海有机化学研究所 吲哚胺-2,3-双加氧酶抑制剂盐及其制备方法
JP7306634B2 (ja) 2017-10-19 2023-07-11 一般社団法人ファルマバレープロジェクト支援機構 Ｉｄｏ／ｔｄｏ阻害剤
CN110092750B (zh) * 2018-01-29 2023-07-21 北京诺诚健华医药科技有限公司 五氟硫烷基取代的酰胺类化合物、其制备方法及其在医药学上的应用
WO2019149159A1 (zh) * 2018-02-02 2019-08-08 山东绿叶制药有限公司 一种包含噁二唑类衍生物的组合物及其制备方法和应用
US11591301B2 (en) * 2018-02-02 2023-02-28 Hinova Pharmaceuticals Inc. Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereof
CN110156674A (zh) * 2018-02-13 2019-08-23 中国科学院上海有机化学研究所 一种作为吲哚胺-2,3-双加氧酶抑制剂的螺环化合物
EP3823604A4 (en) 2018-07-17 2022-03-16 Board of Regents, The University of Texas System COMPOUNDS AS INHIBITORS OF INDOLAMINE-2,3-DIOXYGENASE AND/OR TRYPTOPHANE DIOXYGENASE
US11839659B2 (en) 2020-07-02 2023-12-12 Northwestern University Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1879573T3 (da) * 2005-05-10 2013-02-25 Incyte Corp Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf
ES2540561T3 (es) * 2005-12-20 2015-07-10 Incyte Corporation N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
WO2008036643A2 (en) * 2006-09-19 2008-03-27 Incyte Corporation Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
US20080182882A1 (en) * 2006-11-08 2008-07-31 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CA3012229C (en) * 2008-07-08 2020-11-10 Incyte Holdings Corporation 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
CA2889182A1 (en) * 2012-10-26 2014-05-01 The University Of Chicago Synergistic combination of immunologic inhibitors for the treatment of cancer
CN105481789B (zh) * 2014-09-15 2020-05-19 中国科学院上海有机化学研究所 一种吲哚胺-2,3-双加氧酶抑制剂及其制备方法

Also Published As

Publication number Publication date
EP3196197A1 (en) 2017-07-26
US11053207B2 (en) 2021-07-06
JP6317034B2 (ja) 2018-04-25
CN106687450A (zh) 2017-05-17
US20190152932A1 (en) 2019-05-23
JP2017526727A (ja) 2017-09-14
CN106687450B (zh) 2019-08-16
CN105481789B (zh) 2020-05-19
WO2016041489A1 (zh) 2016-03-24
EP3196197A4 (en) 2018-09-05
CN105481789A (zh) 2016-04-13

Similar Documents

Publication Publication Date Title
US11053207B2 (en) Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor
TWI917498B (zh) Ｓｏｓ１抑制劑、包含其的藥物組合物及其用途
CN105646389B (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的氨基磺酸脂及其制备方法和用途
JP7217752B2 (ja) Ａｃｓｓ２阻害剤およびその使用方法
CN107176933B (zh) 一种含氮烷基化和芳基化亚砜亚胺的吲哚胺-2,3-双加氧酶抑制剂
WO2011137089A1 (en) Activators of human pyruvate kinase
JP2022532718A (ja) Ａｃｓｓ２阻害剤およびその使用方法
JP2021121599A (ja) ヒストンデメチラーゼ阻害剤
WO2016081599A1 (en) Novel mitochondrial uncouplers for treatment of metabolic diseases and cancer
AU2014312245A1 (en) Heterocyclic compounds and methods of use
KR20230012597A (ko) Ampk 활성화제
EP3953335A1 (en) Inhibitors of notch signalling pathway and use thereof in treatment of cancers
KR20200055126A (ko) Ａ2ａ수용체 억제제로서의 축합 고리 유도체
CN110156674A (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的螺环化合物
KR20250009417A (ko) 혈액-뇌 장벽 교차 mll1-wdr5 단백질-단백질 상호작용 저해제 화합물 및 이의 용도
JP2015536987A (ja) ジアシルグリセロールアシルトランスフェラーゼ阻害剤としての新規化合物
AU2017380492B2 (en) Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereof
TW201124401A (en) New phenoxypyrimidine derivatives
JP2020518563A (ja) 抗ガン幹細胞性薬物
WO2019106087A1 (en) Ampk inhibitors
JP2022551180A (ja) イソクエン酸デヒドロゲナーゼ（ｉｄｈ）阻害剤
CN121426801A (zh) 吡唑并吡啶类化合物及其用途
TW201908308A (zh) 苯并咪唑類衍生物及其製備方法及其在醫藥上的用途
BR122025013774A2 (pt) Compostos inibidores da via de sinalização notch, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos
KR20150062813A (ko) 벤조텔루로펜 유도체

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170315

FZDE Dead

Effective date: 20190904